Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Glioblastoma in adults].
Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T. Schipmann-Miletic S, et al. Among authors: sund f. Tidsskr Nor Laegeforen. 2023 Jan 30;143(2). doi: 10.4045/tidsskr.22.0314. Print 2023 Jan 31. Tidsskr Nor Laegeforen. 2023. PMID: 36718891 Free article. Norwegian.
A national precision cancer medicine implementation initiative for Norway.
Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES; CONNECT Public–Private Partnership Consortium; Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R; InPreD-Norway and National Molecular Tumor Board Consortium; IMPRESS-Norway Consortium; Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å. Taskén K, et al. Nat Med. 2022 May;28(5):885-887. doi: 10.1038/s41591-022-01777-4. Nat Med. 2022. PMID: 35513529 No abstract available.
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A. Riise J, et al. Among authors: sund f. Br J Haematol. 2022 Jun;197(6):697-708. doi: 10.1111/bjh.18149. Epub 2022 Mar 21. Br J Haematol. 2022. PMID: 35254660 Free PMC article.
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.
Westman G, Aurelius E, Ahlm C, Blennow K, Eriksson K, Lind L, Schliamser S, Sund F, Zetterberg H, Studahl M. Westman G, et al. Among authors: sund f. Clin Microbiol Infect. 2021 Aug;27(8):1131-1136. doi: 10.1016/j.cmi.2020.09.031. Epub 2020 Sep 23. Clin Microbiol Infect. 2021. PMID: 32979577 Free article. Clinical Trial.
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.
Gnann JW Jr, Sköldenberg B, Hart J, Aurelius E, Schliamser S, Studahl M, Eriksson BM, Hanley D, Aoki F, Jackson AC, Griffiths P, Miedzinski L, Hanfelt-Goade D, Hinthorn D, Ahlm C, Aksamit A, Cruz-Flores S, Dale I, Cloud G, Jester P, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Gnann JW Jr, et al. Clin Infect Dis. 2015 Sep 1;61(5):683-91. doi: 10.1093/cid/civ369. Epub 2015 May 8. Clin Infect Dis. 2015. PMID: 25956891 Free PMC article. Clinical Trial.
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
Lawitz E, Gane E, Pearlman B, Tam E, Ghesquiere W, Guyader D, Alric L, Bronowicki JP, Lester L, Sievert W, Ghalib R, Balart L, Sund F, Lagging M, Dutko F, Shaughnessy M, Hwang P, Howe AY, Wahl J, Robertson M, Barr E, Haber B. Lawitz E, et al. Among authors: sund f. Lancet. 2015 Mar 21;385(9973):1075-86. doi: 10.1016/S0140-6736(14)61795-5. Epub 2014 Nov 11. Lancet. 2015. PMID: 25467591 Clinical Trial.
Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
Lidehäll AK, Engman ML, Sund F, Malm G, Lewensohn-Fuchs I, Ewald U, Tötterman TH, Karltorp E, Korsgren O, Eriksson BM. Lidehäll AK, et al. Among authors: sund f. Scand J Immunol. 2013 Feb;77(2):135-43. doi: 10.1111/sji.12013. Scand J Immunol. 2013. PMID: 23216075 Free article.
14 results